140 related articles for article (PubMed ID: 6290054)
1. Etoposide after ACO treatment for small-cell bronchogenic carcinoma.
Essers U; Knechten H; Seelis R; Ammon J
Cancer Treat Rev; 1982 Jun; 9 Suppl():111-3. PubMed ID: 6290054
[No Abstract] [Full Text] [Related]
2. Combination chemotherapy of small-cell bronchogenic carcinoma with etoposide (VP-16), ifosfamide and vindesine (VPIV), and with adriamycin, cis-platinum and vincristine (APO).
Havemann K
Cancer Treat Rev; 1982 Jun; 9 Suppl():95-100. PubMed ID: 6290059
[No Abstract] [Full Text] [Related]
3. Etoposide as single agent and in combination chemotherapy of bronchogenic carcinoma.
Goldhirsch A; Joss R; Cavalli F; Brunner KW
Cancer Treat Rev; 1982 Jun; 9 Suppl():85-90. PubMed ID: 6290057
[No Abstract] [Full Text] [Related]
4. Small-cell bronchogenic carcinoma--primary and relapse therapy with etoposide (VP-16), methotrexate and CCNU.
Niederle N; Krischke W; Bremer K; Schmidt CG; Seeber S
Cancer Treat Rev; 1982 Jun; 9 Suppl():101-5. PubMed ID: 6290053
[No Abstract] [Full Text] [Related]
5. Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
Johnson DH; Wolff SN; Hainsworth JD; Porter LL; Grosh WW; Hande KR; Greco FA
J Clin Oncol; 1985 Feb; 3(2):170-5. PubMed ID: 2981981
[TBL] [Abstract][Full Text] [Related]
6. Treatment of inoperable non-small-cell bronchogenic carcinoma with etoposide and cis-platinum.
Mitrou PS; Fischer M; Weissenfels I; Diehl V; Gropp C; Liesenfeld A; Schmidt M; Berdel WE; Fink U; Graubner M
Cancer Treat Rev; 1982 Jun; 9 Suppl():139-42. PubMed ID: 6889919
[No Abstract] [Full Text] [Related]
7. Etoposide and cis-platinum in non-small-cell bronchogenic carcinoma.
Klastersky J; Longeval E; Nicaise C; Weerts D
Cancer Treat Rev; 1982 Jun; 9 Suppl():133-8. PubMed ID: 6889918
[No Abstract] [Full Text] [Related]
8. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
[No Abstract] [Full Text] [Related]
9. Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.
Cohen MH; Broder LE; Fossieck BE; Ihde DC; Minna JD
Cancer Treat Rep; 1977; 61(3):489-90. PubMed ID: 194694
[No Abstract] [Full Text] [Related]
10. [Phase II study of VP-16 in patients with primary bronchogenic carcinoma, with special reference to small cell carcinoma--a multi-institutional cooperative study].
Kanda T; Oka M; Hara K; Koteda T; Ishizaki T; Ikebe A; Nakano M; Iwasaki H; Tsutsumi T; Okuno K
Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):12-8. PubMed ID: 3009666
[No Abstract] [Full Text] [Related]
11. Enhanced radiation reaction following combination chemotherapy for small cell carcinoma of the lung, possibly secondary to VP16-213.
Giever RJ; Heusinkveld RS; Manning MR; Bowden GT
Int J Radiat Oncol Biol Phys; 1982 May; 8(5):921-3. PubMed ID: 6286559
[No Abstract] [Full Text] [Related]
12. Management of small cell cancer: intensive chemotherapy.
Smyth JF; Gregor A
Recent Results Cancer Res; 1984; 92():58-64. PubMed ID: 6330811
[No Abstract] [Full Text] [Related]
13. Single-dose etoposide in combination with vincristine and doxorubicin in the treatment of small-cell lung cancer (SCLC).
Timothy AR; Calman FM; Bateman NT; Farebrother M; Slevin ML; Bellamy D; Rubens RD; Costello J
Semin Oncol; 1985 Mar; 12(1 Suppl 2):45-7. PubMed ID: 2983435
[TBL] [Abstract][Full Text] [Related]
14. [Antineoplastic chemotherapy for bronchial carcinoma].
Tanneberger S
Arch Geschwulstforsch; 1985; 55(1):63-71. PubMed ID: 2985017
[TBL] [Abstract][Full Text] [Related]
15. Small cell bronchogenic carcinoma: a cyclical alternating combination of epirubicin plus cisplatin and cyclophosphamide plus etoposide.
Casadio M; Lelli G; Giordani S; Boltri B; Blotta A; Busutti L; Ramini R; Falcone F; Pannuti F
J Chemother; 1990 Jun; 2(3):199-202. PubMed ID: 2166145
[TBL] [Abstract][Full Text] [Related]
16. Etoposide alone and in combination with cyclophosphamide, adriamycin and cis-platinum in patients with Mo and Mi non-small-cell lung cancer.
Eagan RT
Cancer Treat Rev; 1982 Jun; 9 Suppl():119-31. PubMed ID: 6889917
[No Abstract] [Full Text] [Related]
17. [Adriamycin, cyclophosphamide and vincristine (ACO) in small cell bronchial cancer. Course of the disease and long-term follow-up].
Seeber S; Niederle N; Schilcher RB; Schmidt CG
Onkologie; 1980 Feb; 3(1):5-11. PubMed ID: 6258116
[TBL] [Abstract][Full Text] [Related]
18. [Polychemotherapeutic treatment in undifferentiated small cell carcinoma of the lung].
Illiano A; Giacomelli P; Tremiterra E; Scivicco S; Bariffi F; Olivieri D
Arch Monaldi; 1983; 38(1-2):53-7. PubMed ID: 6326702
[No Abstract] [Full Text] [Related]
19. [Clinical study of two chemotherapeutic combinations in the treatment of small-cell bronchogenic carcinoma].
Dangubić V; Vukov N; Mrda V; Spasić D; Sikimić S; Popvić D; Perunović O; Bjelić R
Zb Vojnomed Akad; 1983; 25():40-4. PubMed ID: 6099941
[No Abstract] [Full Text] [Related]
20. Cisplatin, adriamycin, and etoposide (CAV) for remission induction of small-cell bronchogenic carcinoma.
Klastersky J; Nicaise C; Longeval E; Stryckmans P
Cancer; 1982 Aug; 50(4):652-8. PubMed ID: 6284335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
